In Vitro Activities of Ertapenem and Imipenem against Clinical Extended Spectrum Beta-Lactamase-Producing Enterobacteriaceae Collected in Military Teaching Hospital Mohammed V of Rabat

Objective. To study the sensitivity level of extended spectrum beta-lactamase-producing Enterobacteriaceae to Carbapenems (Imipenem, Ertapenem) marketed in Morocco and discusses the place of Ertapenem in the treatment of extended spectrum-beta-lactamase-producing. Materials and Methods. A retrospective study of 110 extended spectrum beta-lactamase-producing Enterobacteriaceae. Isolates obtained from blood cultures, superficial and deep pus, and catheters were conducted. The minimum inhibitory concentrations of Imipenem and Ertapenem were done by the E-test. The modified Hodge test was conducted for resistant or intermediate strains. Results. 99.1% of isolates were susceptible to Imipenem. For Ertapenem, 4 were resistant and 4 intermediate. The modified Hodge test was positive for all 08 isolates. A minimum inhibitory concentration comparison of K. pneumoniae, E. cloacae, and E. coli for Imipenem has noted a significant difference between E. cloacae on one hand and E. coli, K. pneumoniae on the other hand (<0.01). No significant difference was noted for minimum inhibitory concentration of Ertapenem. Conclusion. Our results confirm in vitro effectiveness of Ertapenem against extended spectrum beta-lactamase-producing Enterobacteriaceae as reported elsewhere. However, the emergence of resistance to Carbapenems revealed by production of carbapenemases in this study confirmed a necessary bacteriological documented infection before using Ertapenem

Conduction disturbances in Tako Tsubo cardiomyopathy: A cause or a consequence?

Tako-Tsubo cardiomyopathy (TTC) is a reversible cardiomyopathy mimicking acute myocardial infarction characterized by a transient left ventricular (LV) apical ballooning without epicardial coronary artery disease [1]. Most remarkable is the complete reversibility of this cardiomyopathy resolving spontaneously within several weeks [1]. Conduction pathway disorders were rarely associated with TTC. We described two cases of TTC with conduction disorders persisting after improvement of left ventricular wall motion that finally motivated the implantation of pacemakers

ANTIBIOGRAMME : CHOIX, INTERPRETATION ET LIMITES

L’antibiogramme est un test qui permet de mesurer la capacité d’un antibiotique à inhiber la croissance bactérienne in vitro. Il renseigne, par conséquent, sur la sensibilité des germes vis-à-vis des agents anti-infectieux.Les résultats de l’antibiogramme engagent pleinement la responsabilité du biologiste. En effet, sa décision suppose que la souche isolée est responsable du processus infectieux et incite le clinicien à la mise en route d’une antibiothérapie donnée. Cette mise au point sera axée sur le choix de la méthode adéquate pour la réalisation de l’antibiogramme, la lecture interprétative des résultats et les limites de l’antibiogramme